𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Allergic starch peritonitis in the guinea-pig

✍ Scribed by J. B. F. Grant; J. D. Davies; J. V. Jones


Publisher
John Wiley and Sons
Year
1976
Tongue
English
Weight
302 KB
Volume
63
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

An experimental starch peritonitis in guinea-pigs previously immunized with starch glove powder and Freund's complete adjuvant is described. After peritoneal challenge by 10 mg starch glove powder, 22 per cent of the animals developed florid omental granulomas resembling those found in some patients with postoperative glove powder peritonitis. It is suggested that delayed hyper sensitivity to a component of the glove powder may be responsible for the clinical features of starch peritonitis in man.


πŸ“œ SIMILAR VOLUMES


Spermatozoa in rouleaux in the female gu
✍ Martan, Jan ;Shepherd, Benjamin A. πŸ“‚ Article πŸ“… 1973 πŸ› John Wiley and Sons 🌐 English βš– 459 KB πŸ‘ 2 views

## Abstract Single spermatozoa and spermatozoa in rouleaux were found throughout the genital tract of 21 female guinea pigs killed 15 minutes to 24 hours after copulation. Three females killed three to five minutes postcopulation had single spermatozoa and spermatozoa in rouleaux in the vagini, cer

Cytochrome b558 (p22phox) in the guinea-
✍ Kummer, Wolfgang; KοΏ½nig, Peter; HοΏ½hler, Brigitte πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 427 KB πŸ‘ 1 views

Paraganglionic cells are sensitive to hypoxia, and the involvement of a plasmalemmal cytochrome b558-like protein in oxygen sensing by these cells has been suggested, but neither the identity of the immunoreactive protein detected by immunohistochemistry nor its anticipated subcellular (i.e., plasma

Prevention of experimental allergic ence
✍ Dr. Frank C.-H. Chou; C.-H. Jen Chou; Robert B. Fritz; Robert F. Kibler πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 English βš– 374 KB

## Abstract The highly encephalitogenic guinea pig peptide 68‐88 has been used to develop an effective and reproducible model of protection in the Lewis rat. Doses as low as 0.1 nmol of peptide protected 70% of rats when injected intraperitoneally six and four weeks prior to challenge with 0.05 nmo